Systematic review of GLP-1 drug effects on mortality across conditions provides comprehensive evidence for their life-extending potential.
Key findingSystematic review of GLP-1 drug effects on mortality across conditions provides comprehensive eviden
What the researchers found
Systematic review of GLP-1 drug effects on mortality across conditions provides comprehensive evidence for their life-extending potential.
Why it matters
Relevant to peptide therapeutics.
How the study worked
In publication.
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: Target engagement and rationale for the development in mental disorders.
Journal of affective disorders, 370, 321-327
Citation
Au, Hezekiah C T; Zheng, Yang Jing; Le, Gia Han; Wong, Sabrina; Phan, Lee; Teopiz, Kayla M; Kwan, Angela T H; Rhee, Taeho Greg; Rosenblat, Joshua D; Ho, Roger; McIntyre, Roger S. (2025). A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: Target engagement and rationale for the development in mental disorders.. Journal of affective disorders, 370, 321-327. https://doi.org/10.1016/j.jad.2024.11.019